IDEXX Laboratories is maintaining its organic sales growth estimates for 2020 but has increased its revenues guidance.The firm recently published its Q4 and FY19 results, which featured annual sales growth of 9% - slightly above projections issued inthe previous quarter. During an analyst call, the firm's chief financial officer and executive vice president Brian McKeon said: "We're well positioned to build on these strong results in 2020. We're maintaining our outlook for 9% to 10.5% organic revenue growth reflected in our increased guidance range of $2.62 billion to $2.655 billion in annual revenues, which include updated foreign exchange estimates.
展开▼
